Dabur India Limited. Investor Presentation June 2018

Similar documents
Dabur India Limited Investor Presentation CLSA India Forum November 2018

Dabur India Limited. Investor Presentation November December 2018

Investor Presentation February 2016

Dabur India Limited Investor Communication

Investor Communication. Quarter and Half Year ended 30 th September, 2016

Dabur India Limited. Investor Communication. Quarter ended 30 th June August 4, 2017

GODREJ CONSUMER PRODUCTS INVESTOR PRESENTATION

Dabur India Limited. Investor Communication. Quarter and Half Year ended September 30, 2014

GODREJ CONSUMER PRODUCTS INVESTOR PRESENTATION JUNE 2013

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

Business snapshot. ~50% of revenues comes from international businesses. Leading market share in home care, hair care and personal care

Dabur India. Neutral. Rs93

Business snapshot. ~50% of revenues comes from international businesses. Leading market share in home care, hair care and personal care

PRESS RELEASE. Mumbai, January 27, 2016: Godrej Consumer Products Limited (GCPL), a leading

DABUR INDIA LTD Result Update (CONSOLIDATED BASIS): Q3 FY19

Pioneers of laminated tubes in India. Corporate Presentation

KRBL LIMITED. Investor Communication

Dabur India. CMP: INR130 TP: INR135 Neutral

Dabur. Bargain hunting BUY COMPANY UPDATE 12 DEC CMP (as on 12 Dec 2013) Rs 168 Target Price Rs 192

Business snapshot. 48% of revenue comes from international businesses. Leading market share in home care, hair care and personal care

Dabur India. CMP: INR106 TP: INR94 Neutral

DABUR INDIA LIMITED RESEARCH

Performance Update - 4Q FY16 May 3, 2016

Dabur India (DABIND) 276

GODREJ CONSUMER PRODUCTS LIMITED 1Q FY2016 PERFORMANCE UPDATE

PRESS RELEASE. Mumbai, May 3, 2016: Godrej Consumer Products Limited (GCPL), a leading emerging

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

INVESTOR PRESENTATION JANUARY Version -3

Dabur India (DABIND) 287

Performance Update - 4Q FY18 May 8, 2018

DABUR Going from strength to strength

Dabur India (DABIND) 290

Dabur India. Institutional Equities. 1QFY19 Result Update

Dabur India Ltd. Q3FY18 Result Update Strong Volume led Domestic growth; IBD remains weak. Sector: FMCG CMP: ` 356. Recommendation: BUY

BUY. BAJAJ CORP LIMITED Result Update: Q1 FY14. CMP (Rs) Target Price (Rs) AUGUST 10 th, 2013 HIGHLIGHTS

Performance Update - 2Q FY16 October 24, 2015

PRESS RELEASE. Mumbai, January 30, 2017: Godrej Consumer Products Limited (GCPL), a leading

DABUR INDIA LIMITED Half Yearly Financial Report A Fresh Outlook

Dabur India (DABIND) 304

Dabur India (DABIND) 275

Dabur India. Source: Company Data; PL Research

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Uncommon sense. April 2009

PRESS RELEASE. de-stocking; consolidated net profit without exceptional items is INR 230 crore

BUY. Big beneficiary of rural recovery; BUY DABUR INDIA. Target Price: Rs 395. Key drivers (%) FY18E FY19E FY20E

TCS Financial Results

Dabur India. Result Update Q3 FY15. Dabur matched our expectations by recording modest 9.2% yoy revenue

BUY SIMPLEX INFRASTRUCTURES LTD SYNOPSIS. CMP Target Price FEBRUARY 28 th Result Update (PARENT BASIS): Q3 FY15

Dabur India (DABIND) 355

Deutsche Bank Conference. Paris June 11th, 2007

DABUR Healthy and juicy

Recovery to be gradual; Maintain HOLD

TCS Financial Results

Unilever - CAGE Conference. Paul Polman CEO Roger Seabrook VP Investor Relations London - 19 th March 2012

Hindustan Unilever Limited. SQ 18 Results Presentation : 12 th October 2018

Investor Presentation. December 2012

Q2FY18 Performance Review 25 th October 2017

Performance Update - 3Q FY18 January 30, 2018

EARNINGS PRESENTATION 9M/Q3-FY2018

Colgate TEAM ID Recommendation: SELL Market Cap: Rs Cr. 5,166.64

Accelerating our IPT strategy

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Aurobindo Pharma Limited Presentation to Investors

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015

COLGATE-PALMOLIVE (INDIA) LTD Result Update (PARENT BASIS): Q1 FY15

LUPIN LIMITED. Q2 FY17 Investor Presentation November 09, Aerial view of Lupin offices, Baltimore, US

Presentation at Citigroup Smith Barney India Corporate Day. London, June 2003

Aurobindo Pharma Limited. Presentation to Investors

Greenply Industries Ltd. Results Presentation Q1 FY16

ANNUAL GENERAL MEETING

MQ 2015 & FY Results Presentation May 8, 2015

BUY. KDDL LTD Result Update (PARENT BASIS): Q1 FY16 SYNOPSIS. CMP Target Price AUGUST 22 nd 2015 ISIN: INE291D01011

CHANGE IN STANCE DABUR IN EQUITY June 13, 2017

RESULTS FOR THE QUARTER ENDING 31 st MARCH % COMPARABLE* DOMESTIC CONSUMER GROWTH, 11% UNDERLYING VOLUME GROWTH

Firstsource Solutions Limited Q4 and FY2018 Earnings Update

INVESTOR PRESENTATION APRIL

Juice Market India September 2014

William Blair 35 th Annual Growth Stock Conference. June 9, 2015 NYSE: Q. Copyright 2014 Quintiles

Osotspa Public Company Limited

Hindustan Unilever Limited. MQ 18 & FY Results Presentation : 14 th May 2018

MANPASAND BEVERAGES LTD Result Update (PARENT BASIS): Q2 FY18

Wipro Limited. April June Presentation to Investors 2015 WIPRO LTD

Credit Suisse 6 th Annual Industrials Conference November 2018

Investor Deck December 2018

DABUR Volumes in revival mode; GST key monitorable

Bank of America Merrill Lynch The Future of Financials Conference. November 14, Citi Investor Relations

GODREJ INDUSTRIES LIMITED Performance Update Q2& H1 FY I Godrej Industries Limited I Q2 & H1 FY Performance Update Nov 14,2017

DABUR INDIA LIMITED HALF YEARLY FINANCIAL REPORT

Welcome to Colgate-Palmolive India COLGATE-PALMOLIVE (INDIA) LIMITED ANALYST MEET OCT

Investor Presentation. February 2012

Our Transformation Continues. March 21, 2018

Hindustan Unilever Ltd.

PDF processed with CutePDF evaluation edition

November Rick Goings. Chairman & CEO

Godrej Consumer Products

BUY ASIAN PAINTS LTD. Result Update (CONSOLIDATED BASIS): Q2 FY16. CMP Target Price OCTOBER 24 th 2015 SYNOPSIS

Hathway Cable and Datacom Limited Investor Update Q2-FY18

India : Building scale and leadership. Pankaj Razdan Prudential Corporation Asia 1 December 2006

S H Kelkar and Company Limited

CORPORATE INFORMATION

Transcription:

Dabur India Limited Investor Presentation June 2018 1

Contents 1. Dabur Overview 2. Business Structure 3. India Business 4. The Journey of our Gems 5. International Business 6. The next growth wave 7. Annexure 2

Dabur Overview Overview Awards Established in 1884 134 years of trust and excellence One of the world s largest in Ayurveda and natural healthcare Having one of the largest distribution network in India, covering 6.3 mn outlets Dabur Red Paste rated as 2nd most trusted brand by the consumers in the Oral Care category by the Brand Equity India s Most Trust Brand 2017 Dabur Vatika #BraveandBeautiful campaign wins 2 Effies 20 world class manufacturing facilities catering to needs of diverse markets Strong overseas presence with ~28% contribution to consolidated sales Market cap: US$ 10bn Dabur moves up 4 Places in Fortune India 500 List; ranked 163 in the list for 2015 Dabur ranked 25 in the list of Best Companies for CSR in India, according to the Economic Times Dabur India successfully held the firstever Guinness World Record attempt for the largest simultaneous Nasya Panchkarma Treatment session INR:USD F/X Rate: 68.5 3

Key milestones Established by Dr. S.K. Burman in Kolkata Acquired Balsara Foods business crossed INR 10.0 bn turnover mark Inducted professional management Acquired Hobi and Namaste 1884 1994 1998 2000 2005 2008 2010 2012 2016 2018 Crossed the INR 10.0 bn turnover mark Crossed the USD 1 bn turnover mark Came out with first public issue Acquired Fem Pharma Crossed market cap of $10 bn 4

Dabur & Ayurveda Ayurveda = Dabur s Core Philosophy Synonymous with Ayurveda since 133 years Known for making Ayurveda accessible to every household in India Anchored by Heritage Stringent quality test of every ingredient and herb Strong R&D infrastructure including in-house Ayurvedic doctors & scientists Over 5,000 acres of cultivation of endangered herbs and plants Propelled by Science Governed by Trust 5

Manufacturing facilities 12 manufacturing locations in India 8 international manufacturing locations UAE Jammu Newai Alwar ` Baddi Sahibabad Pantnagar Tezpur Egypt Nigeria Katni South Africa Silvasa Nasik Pithampur Narendrapur Turkey Sri Lanka Bangladesh Nepal 6

Distribution Network Urban Rural Factory Factory C&F C&F GT Stockist MT Stockist Insti Stockist Super Stockist Wholesaler Sub Stockist Retailer Retailer Retailer Consumer Consumer Consumer Consumer Distribution reach of 6.3 mn retail outlets with direct reach of 1 mn 7

Strong Financial Profile Revenue from Operations 28.1 34.0 41.0 53.1 61.7 CAGR : 11.9% 70.9 78.3 78.7 77.0 77.5 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 Revenue has become ~3x over the last 10 years Last 3 years revenue looks optically static due to change in accounting standards, demonetization and implementation of GST Operating Profit 16.9% 4.7 Operating Profit Operating Margins (%) 20.9% 18.9% 19.5% 19.3% 19.6% 16.8% 16.0% 16.6% 16.7% 15.2 15.1 16.2 11.8 13.1 6.4 8.0 8.9 9.9 In FY18, the operating margin of 20.9% was the highest ever in the history of the company FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 PAT Profit After Tax (PAT) PAT Margins (%) 15.9% 16.6% 17.5% 13.8% 14.7% 13.9% 12.1% 12.4% 13.2% 13.5% 12.5 12.8 13.5 3.9 5.0 5.7 6.4 7.6 9.3 10.5 FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 PAT has grown at a CAGR of 15% over the last 10 years PAT margin is the highest ever in the history of the company Note: All figures are in INR bn FY09 to FY15 is basis IGAAP, FY16 and FY17 are as per IndAS and FY18 is as per IndAS and takes into account GST 8

Contents 1. Dabur Overview 2. Business Structure 3. India Business 4. The Journey of our Gems 5. International Business 6. The next growth wave 7. Annexure 9

Business structure Domestic (72%) International (28%) Domestic FMCG (68%) Others (4%) Organic (67%) Acquired (33%) Note: Figures in brackets are based on FY18 revenue 10

Contents 1. Dabur Overview 2. Business Structure 3. India Business 4. The Journey of our Gems 5. International Business 6. The next growth wave 7. Annexure 11

Sales by Business Vertical Domestic FMCG Business Verticals 1 Key categories Domestic FMCG Category Revenue Contribution (FY18) Key Brands Hair Care 21% Healthcare (32%) Foods 18% HPC (50%) Health Supplements 17% Foods (18%) Oral Care 17% OTC & Ethicals 9% Others 2 18% 1. Based on FY18 Revenue 2. Others includes Digestives, Skin Care and Home Care 12

Market leader in 6 categories Leading position in key categories across verticals #Relative Competitive Position 1 #1 #1 #2 #2 #2 #3 #1 #2 #1 #1 #1 Honey Chyawanprash Baby Massage Oil Glucose Hair Oils Oral Care Skin Care - Bleaches Toilet Cleaners Air Fresheners Mosquito Repellant Creams Juices Healthcare Home and Personal Care Foods 1. Position basis Nielsen Market Share data MAT Mar 18 13

Building bigger brands 10 bn+ 1 bn+ 16 brands with turnover of INR 1bn+ with 3 brands which are INR 10bn+ 14

Recent Innovations Vatika Shampoo with Satt Poshan Vatika Enriched Coconut Hair Oil Anmol Jasmine Hair Oil GlycoDab Tablets (Ayurvedic Medicine) Odonil Zipper Real Koolerz 15

Business strategy Healthcare Home & Personal Care Foods Leadership in Ayurveda scientific evidence & research OTC portfolio to be scaled up through innovation & awareness creation Doctor advocacy through Medico Marketing channel Ayurvedic / Herbal focus Premiumization & Differentiation Strong innovation agenda Potential to expand in adjacencies within current categories Maintain leadership in Juices & Nectars category Leveraging the Fruit equity associated with the Real brand Focus on Healthy range of products 16

Contents 1. Dabur Overview 2. Business Structure 3. India Business 4. The Journey of our Gems 5. International Business 6. The next growth wave 7. Annexure 17

Odonil s Journey Led by constant innovation and evolving communication Revenue Trajectory Market Share % - MAT 2018 Odonil has become 9x in the last 12 years x CAGR: 20% 3.3x 9x and is the market leader in the air fresheners category ~50% ~14% FY06 FY12 FY18 Odonil Next biggest player FY06 FY11 FY13 FY15 FY18 Led by constant innovation and new launches in the space and Blocks Pluggy Gel 1 Touch Air Sanitizer Zipper Supported by evolving communication themes and advertisements Till FY07 Mal Odor Removal FY07 to FY11 Transformation(Mood) FY11 to FY16 Transformation(Space) Since FY16 Social Necessity 18

Dabur s journey to become the 3 rd largest toothpaste company in India Over the last 15 years, Dabur has grown from a tooth powder company to one of the top 3 players in the toothpaste category Entered the toothpaste category with the launch of Dabur Red Paste in 2004 Acquisition of Balsara in 2005 added Babool and Meswak brands to the herbal oral care portfolio Recently launched Dabur Red Gel to capture Ayurvedic segment among Gel users Growing at a rapid pace, Dabur has become the third largest toothpaste company in the country and has a strong innovation pipeline Consistent increase in market share of Dabur in the toothpaste category +350 bps +150 bps +160 bps Mar-06 Mar-08 Mar-11 Mar-18 19

Real continues on the journey of dominance in J&N category Real Fruit Power Real Activ Real Wellnezz Real Koolerz Real Mocktails Real Activ Coconut Water Real Fruit Juices were launched in 1998 to create the packaged fruit juice category in India First to launch variants like Litchi, Guava, Pomegranate, Cranberry, Supafruits, Mosambi and the Activ range of fruit and veggie blends More than 30 variants in the portfolio currently Continuing to be the market leader with >50% share Recently launched Real Koolerz to enter the drinks category Strong innovation pipeline to cater to consumers across the spectrum 20

Contents 1. Dabur Overview 2. Business Structure 3. India Business 4. The Journey of our Gems 5. International Business 6. The next growth wave 7. Annexure 21

International Business Financial Profile Sales (INR bn) CAGR: 14% International Business comprises the Organic and Acquired business 16.2 18.3 23.1 24.2 27.1 23.2 21.8 Organic business (67% of international) is an extension of Indian portfolio with the same personal care brands operating internationally Acquired business (32% of international) comprises Hobi and 8.9 Namaste FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 Region-wise Sales (FY18) FY17 and FY18 were impacted due to geopolitical headwinds and severe currency devaluation in our key markets Performance of Key Markets (FY18) Europe 10.8% Americas 14.0% Middle East 34.0% 31.8% Constant Currency Growth Rate FY18 17.3% 16.9% 13.7% 10.7% 10.6% 10.0% Asia 22.4% Africa 18.8% Egypt GCC Saudi Arabia (15.8%) Nigeria Nepal Turkey Namaste SSA 22

Organic International Business FY06 FY18 Oral Care 2% Others 5% Skin Care 7% Oral Care 12% Others 10% Hair Oil 34% Hair Oil 93% Hamamzaith & Styling 9% Shampoo 17% Hair Cream 11% Organic International Business has evolved from being just a Hair Oil business to a diversified personal care entity 23

Acquired International Business Namaste Hobi Key Geographies USA Africa Key Categories Straighteners Styling Shampoo & Conditioners Key Geographies Turkey Key Categories Hair Styling Shampoo & Conditioners Liquid Soap Skin & Body Care 24

International Business Strategy Brands positioned on Herbal and Natural platform Product portfolio customized to local preferences Strong investments in brands and business Leveraging Digital platform to enhance consumer awareness and brand visibility Local supply chain & management offers strategic advantage 25

Contents 1. Dabur Overview 2. Business Structure 3. India Business 4. The Journey of our Gems 5. International Business 6. The next growth wave 7. Annexure 26

The next growth wave Build bigger brands More than 15 brands in the range of INR >0.1 to 1 bn which can grow to INR 1bn+ Continued Innovation NPD pipeline primed to deliver new products in key categories 4-5 new products every year Driving distribution expansion Direct reach of 1 mn +, increasing the no. of SKUs, rural potential, IT enablement, data analytics Consumer Health Strong core competence, low competitive intensity, strong profitability, low penetration Geographical expansion Expand into overseas focus markets where our brands are relevant MENA, Africa, SAARC 27

Contents 1. Dabur Overview 2. Business Structure 3. India Business 4. The Journey of our Gems 5. International Business 6. The next growth wave 7. Annexure 28

Shareholding, Market Cap and Dividends Shareholding pattern Market Cap (INR bn) FIIs 17.6% DIIs 8.6% Retail 5.7% 439 488 576 678 Promoters 68.1% Dividend history Mar-16 Mar-17 Mar-18 May-18 750% 175% 200% 115% 130% 150% 175% 200% 225% 225% 1. Normal dividend of 250%, 2. Special Dividend of 500% to commemorate the 25 years of listing FY09 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 29

Select Advertisements May 2018 30

Select Advertisements May 2018 31

Consolidated Profit & Loss Q4 FY18 Q4 FY17 Y-o-Y (%) FY18 FY17 Y-o-Y (%) Revenue from operations 2,032.9 1,914.7 6.2% 7,748.3 7,701.4 0.6% Other Income 73.2 65.0 12.6% 305.2 298.3 2.3% Total Income 2,106.1 1,979.7 6.4% 8,053.5 7,999.8 0.7% Material Cost 1,002.4 976.1 2.7% 3,846.4 3,843.2 0.1% % of Revenue 49.3% 51.0% 49.6% 49.9% Employee expense 180.7 173.1 4.4% 792.8 789.6 0.4% % of Revenue 8.9% 9.0% 10.2% 10.3% Advertisement and publicity 125.6 123.0 2.1% 606.7 646.1 (6.1%) % of Revenue 6.2% 6.4% 7.8% 8.4% Other Expenses 239.0 224.9 6.3% 885.0 913.5 (3.1%) % of Revenue 11.8% 11.7% 11.4% 11.9% Operating Profit 485.2 417.6 16.2% 1,617.4 1,508.9 7.2% % of Revenue 23.9% 21.8% 20.9% 19.6% EBITDA 558.4 482.6 15.7% 1,922.6 1,807.3 6.4% % of Revenue 27.5% 25.2% 24.8% 23.5% Finance Costs 13.2 11.7 13.5% 53.0 54.0 (1.8%) Depreciation & Amortization 42.6 39.5 7.7% 162.2 142.9 13.5% Profit before exceptional items, tax and share of profit/(loss) from joint 502.6 431.4 16.5% 1,707.4 1,610.4 6.0% venture % of Revenue 24.7% 22.5% 22.0% 20.9% Share of profit / (loss) of joint venture (0.2) (0.1) n.m. 0.2 0.3 (5.6%) Exceptional item(s) 0.0 0.0 n.a. 14.5 0.0 n.a. Tax Expenses 105.2 97.7 7.7% 335.4 330.3 1.5% Net profit after tax and after share of profit/(loss) from joint venture 397.2 333.7 19.0% 1,357.7 1,280.3 6.0% % of Revenue 19.5% 17.4% 17.5% 16.6% Non controlling interest 1.0 0.5 81.2% 3.3 3.4 (0.7%) Net profit for the period/year 396.2 333.1 18.9% 1,354.4 1,276.9 6.1% % of Revenue 19.5% 17.4% 17.5% 16.6% Note: All figures are in INR crores, unless otherwise stated 32

Consolidated Balance Sheet (1 of 2) All figures are in INR crores, unless otherwise stated Particulars As at 31/03/2018 (Audited) As at 31/03/2017 (Audited) A Assets 1 Non-current assets (a) Property, plant and equipment 1,552 1,479 (b) Capital work-in-progress 42 42 (c) Investment property 54 55 (d) Goodwill 412 411 (e) Other Intangible assets 10 14 (f) Financial assets (i) Investments 3,092 2,499 (ii) Loans 13 12 (ii) Others 4 4 (g) Other non-current assets 3 3 (h) Non-current tax assets (net) 80 95 Total Non-current assets 5,262 4,615 2 Current assets (a) Inventories 1,256 1,107 (b) Financial assets (i) Investments 713 741 (ii) Trade receivables 706 650 (iii) Cash and cash equivalents 154 163 (iv) Bank Balances other than (iii) above 152 142 (v) Loans 35 11 (vi) Others 28 14 (c) Current Tax Asset(Net) 2 0 (d) Other current assets 391 290 (e) Assets held for sale 2 0 Total current assets 3,440 3,117 Total Assets 8,702 7,732 33

Consolidated Balance Sheet (2 of 2) All figures are in INR crores, unless otherwise stated Particulars As at 31/03/2018 (Audited) As at 31/03/2017 (Audited) B Equity and Liabilities 1 Equity (a) Equity share capital 176 176 (b) Other Equity 5,530 4,671 Equity attributable to shareholders of the Company 5,707 4,847 Non Controlling Interest 27 25 Total equity 5,733 4,872 2 Non-current liabilities (a) Financial liabilities (i) Borrowings 364 471 (ii) Other financial liabilities 4 4 (b) Provisions 56 53 (c) Deferred tax liabilities (Net) 109 108 Total Non-current liabilities 534 636 3 Current liabilities (a) Financial liabilities (i) Borrowings 464 440 (ii) Trade payables 1,410 1,309 (iii) Other financial liabilities 238 174 (b) Other current liabilities 173 169 (c) Provisions 107 93 (d) Current tax Liabilities (Net) 41 38 Total Current liabilities 2,434 2,224 Total Equity and Liabilities 8,702 7,732 34

For more information & updates, visit http://www.dabur.com/in/en-us/investor